IFFO2 Inhibitors
FFO2, also known as Inhibitor of F-box proteins 2, is a crucial regulator within the cellular milieu, intricately involved in controlling protein turnover and cellular homeostasis. Functionally, IFFO2 operates as a negative regulator of the ubiquitin-proteasome system (UPS), specifically influencing the activity of F-box proteins. F-box proteins play a pivotal role in substrate recognition for ubiquitination, marking proteins for degradation by the proteasome. IFFO2's inhibitory role in this process is paramount for maintaining proper cellular protein levels and preventing aberrant degradation. The cellular processes governed by IFFO2 are tightly linked to various signaling pathways and molecular events. As a negative regulator of F-box proteins, IFFO2 modulates the ubiquitination and subsequent degradation of specific protein targets, influencing their abundance and function within the cell. This regulatory function extends to proteins involved in crucial cellular pathways, including cell cycle progression, signal transduction, and apoptosis. By selectively inhibiting IFFO2, the delicate balance within these pathways can be disrupted, leading to altered cellular responses and phenotypes.
The inhibition of IFFO2 by the aforementioned chemicals operates through diverse mechanisms, targeting key nodes within signaling cascades associated with F-box protein regulation. For example, compounds like A-769662 and Compound C indirectly impact IFFO2 by modulating AMP-activated protein kinase (AMPK) activity, thereby influencing cellular energy homeostasis and downstream events connected to IFFO2 regulation. Similarly, inhibitors like CX-4945 and JQ1 exert their effects by targeting casein kinase 2 (CK2) and bromodomain and extraterminal domain (BET) proteins, respectively, establishing connections between these regulatory proteins and IFFO2-associated cellular processes. Understanding the intricate network of IFFO2 inhibition provides valuable insights into the broader context of cellular regulation and protein turnover. Further exploration of these chemical inhibitors elucidates the interconnected pathways and molecular events that converge on IFFO2, highlighting its pivotal role in maintaining cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A potent AMP-activated protein kinase (AMPK) activator, indirectly inhibiting IFFO2. By activating AMPK, it enhances cellular energy homeostasis, influencing downstream pathways involved in IFFO2 regulation. This leads to reduced activity of IFFO2 through modulation of its associated signaling cascades. | ||||||
BAY 61-3606 | sc-507485 | 2 mg | $345.00 | 1 | ||
A selective Syk inhibitor, indirectly affecting IFFO2 by impeding signaling pathways reliant on Syk activity. This disruption alters the phosphorylation events and downstream signaling, contributing to the inhibition of IFFO2. The compound's action on Syk establishes a regulatory node influencing IFFO2-associated cellular processes. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 inhibitor impacting the Wnt pathway indirectly, leading to downstream effects on IFFO2. By inhibiting GSK-3, it alters Wnt signaling dynamics, affecting cellular events associated with IFFO2 activity. The compound establishes a link between Wnt pathway modulation and the inhibition of IFFO2, contributing to a regulatory framework within the cellular milieu. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
A potent inhibitor of AMPK, directly influencing IFFO2 by disrupting AMPK-mediated signaling cascades. This compound impedes the activation of AMPK, leading to alterations in downstream pathways connected to IFFO2 regulation. The inhibition of IFFO2 is a consequence of the disrupted cellular energy homeostasis caused by the inhibition of AMPK. | ||||||
CX-4945 | 1009820-21-6 | sc-364475 sc-364475A | 2 mg 50 mg | $183.00 $800.00 | 9 | |
A selective inhibitor of casein kinase 2 (CK2), indirectly inhibiting IFFO2 by disrupting CK2-mediated signaling pathways. By impeding CK2, it influences downstream events that regulate IFFO2, establishing a connection between CK2 modulation and the inhibition of IFFO2. The compound serves as a molecular tool to decipher the intricate network governing IFFO2 activity. | ||||||
EHT 1864 | 754240-09-0 | sc-361175 sc-361175A | 10 mg 50 mg | $213.00 $889.00 | 12 | |
Rac family GTPase inhibitor, indirectly impacting IFFO2 by modulating cellular processes dependent on Rac GTPases. The compound disrupts the signaling events mediated by Rac GTPases, leading to downstream effects on IFFO2 activity. Through its action on Rac GTPases, it establishes a regulatory axis influencing the cellular milieu associated with IFFO2 regulation. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
A potent pan-class I PI3K inhibitor, indirectly influencing IFFO2 by disrupting PI3K-mediated signaling pathways. By inhibiting PI3K, it alters downstream events connected to IFFO2, establishing a link between PI3K modulation and the inhibition of IFFO2. The compound serves as a pharmacological tool to explore the intricate web of signaling cascades governing IFFO2 activity. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A bromodomain and extraterminal domain (BET) protein inhibitor, indirectly influencing IFFO2 by modulating transcriptional events. By inhibiting BET proteins, it alters the expression of genes involved in pathways associated with IFFO2, establishing a link between transcriptional regulation and the inhibition of IFFO2. The compound serves as a tool to explore the transcriptional control of IFFO2 activity. | ||||||
PF-562271 | 717907-75-0 | sc-478488 sc-478488A sc-478488B | 5 mg 10 mg 50 mg | $312.00 $474.00 $1124.00 | 3 | |
FAK inhibitor, indirectly influencing IFFO2 by disrupting focal adhesion kinase (FAK)-mediated signaling pathways. By inhibiting FAK, it alters downstream events connected to IFFO2, establishing a link between FAK modulation and the inhibition of IFFO2. The compound serves as a molecular tool to explore the intricate web of signaling cascades governing IFFO2 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, indirectly inhibiting IFFO2 by disrupting p38 MAPK-mediated signaling pathways. By inhibiting p38 MAPK, it alters downstream events connected to IFFO2, establishing a link between p38 MAPK modulation and the inhibition of IFFO2. The compound serves as a pharmacological tool to dissect the complex signaling network governing IFFO2 activity. | ||||||